Polymorphic form of n -{6 -(2 -hydroxoxypropan -2 -yl)-2 -[2 -(methylsulfonyl)ethyl]-2h -indazol -5 -yl}-6 -(trifluoromethyl)pyridine -2 -carboxamide. This invention refers to crystalline forms of n -{6 -(2 -hydroxoxypropan -2 -yl)-2 -[2 -(methylsulfonyl)ethyl]-2h -indazol -5 -yl}-6 -(trifluoromethyl)pyridine -2 -carboxamide, processes for their preparation, pharmaceutical compositions that constitute them and their use in disease control.forma polimórfica de n-{6-(2-hidróxipropan-2-il)-2-[2-(metilsulfonil)etil]-2h-indazol-5-il}-6-(trifluorometil)piridina-2-carboxamida. a presente invenção se refere a formas cristalinas de n-{6-(2-hidróxipropan-2-il)-2-[2-(metilsulfonil)etil]-2h-indazol-5-il}-6-(trifluorometil)piridina-2-carboxamida, a processos para sua preparação, a composições farmacêuticas que as constitui e a seu uso no controle de doenças.
